fashion -WSS

fashion

author：Wikipedia 2025-09-05 13:43:56 - browse：1341

A person wears a headset projecting a brain -- health tech coverage from STAT — Adobe

Just as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device company Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment for the neurodegenerative disease.

With the new Series B extension funding, the Cambridge, Mass.-based company has now raised $128 million to develop its headset that uses gamma frequency light and sound stimulation to combat the cognitive decline that’s the hallmark of Alzheimer’s. Cognito is currently undertaking a large study of the treatment and CEO Brent Vaughan told STAT he expects the company to complete the trial and submit data to the Food and Drug Administration for review by the end of 2025.

While under treatment, patients use the device for one hour per day in their homes. The light and sound is supposed to stimulate brain activity that’s disrupted by neurodegenerative conditions, potentially helping to preserve brain structure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： The 10 drugs up first for Medicare price negotiation

WSS

Amazon on where the company's health care bets are headed next

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Ethical issues complicate the benefits of medical crowdfunding

STAT readers on older presidents, polypills, Medicare, and more

Illumina names Agilent executive as new CEO

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

focus

fashion

entertainment

Moonlake's readout produced a cash windfall. Risks remain

He's a Nobel laureate. Critics say he was misleading on Covid

Apple is now the first public company to be valued at $3 trillion

Alabama IVF ruling threatens families facing fatal genetic disease

Walensky prepares to leave CDC — and Congress — behind

With competition flaring, obesity drug hits goal in liver disease study

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Obesity drugs seen as possible treatment for liver disease MASH

Affirmative action in medical school literally saved lives

Stem cell treatment guidelines are released by FDA

hotspot

With competition flaring, obesity drug hits goal in liver disease study

Medicare inequities exacerbate Puerto Rico’s health disparities

How generative AI is inspiring dreams of a health data revolution

Community Health Systems hospitals under DOJ investigation

NIH nominee Bertagnolli will get October confirmation hearing

New documents shed light on MD Anderson Cancer Institute feud

leisure time

entertainment

leisure time

Wikipedia